retina

Close-up of human eye
Biotech

Atsena gene therapy hits safety goals, closes retinal splits

Gene therapy outfit Atsena Therapeutics has debuted data showing its eye disease candidate led to no serious treatment-related adverse events.
Darren Incorvaia May 19, 2025 12:59pm
graphic of a larger shark chomping up a smaller one

Regeneron snaps up eye biotech, snaring science but not staff

Jan 2, 2025 3:58pm
close-up image of an eye

Atsena downsizes to funnel money toward new capsid program

Oct 5, 2023 1:47pm
Zeiss Medical Technology eye

Zeiss, Boehringer eye retinal disease-focused predictive AI pact

Oct 2, 2023 1:00pm
iris eye eyeball eye art

Cash-strapped eye disease biotech halves portfolio

Aug 8, 2023 2:36pm
Closed sign in the window of a bar

Vedere Bio II, unimpressed by preclinical work, shuts down

Apr 3, 2023 10:35am